New virulent bacteriophages active against multiresistant Pseudomonas aeruginosa strains

被引:2
|
作者
Balarjishvili, N. Sh. [1 ]
Kvachadze, L. I. [1 ]
Kutateladze, M. I. [1 ]
Meskhi, T. Sh. [1 ]
Pataridze, T. K. [1 ]
Berishvili, T. A. [1 ]
Tevdoradze, E. Sh. [1 ]
机构
[1] G Eliava Inst Bacteriophages Microbiol & Virol, GE-0160 Tbilisi, Georgia
关键词
Pseudomonas aeruginosa; antibiotic resistance; bacteriophages; lytic activity; antimicrobial phage-based preparation; FIELD GEL-ELECTROPHORESIS; THERAPY; INFECTIONS; PHAGE; MICE; PATTERNS; DIARRHEA;
D O I
10.1134/S0003683815060034
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
The sensitivity of 512 newly isolated Pseudomonas aeruginosa clinical strains to six classes of antimicrobial preparations has been studied. Antibiotic-resistant strains were selected and genotyped. Three new virulent bacteriophages of the families Myoviridae and Podoviridae were isolated against these strains. The parameters of the intracellular phage development cycle were established, and the influence of inactivating factors (temperature, pH, and UV exposure) on phage viability was studied. The molecular weight of the phage genome was determined. Phage DNA restriction analysis and structural protein composition analysis by SDS polyacrylamide gel electrophoresis were carried out. The plating efficacy of phages on 28 genetically distant antibiotic-resistant P. aeruginosa strains was studied. It was established that 26 of them were lysed by phages with a high efficacy. The range of antibacterial action of the studied phages and their mixtures on 427 multidrug-resistant clinical isolates was assessed. It is shown that including these phages in one multicomponent preparation enhanced their lytic activity.
引用
收藏
页码:674 / 682
页数:9
相关论文
共 50 条
  • [41] Colimycin therapy for multiresistant Pseudomonas aeruginosa cholangitis
    N'Guyen, Y.
    Hentzien, M.
    Goehringer, F.
    Garnier, V. Vernet
    Strady, C.
    MEDECINE ET MALADIES INFECTIEUSES, 2012, 42 (08): : 366 - 369
  • [42] Bacteriophages for the treatment of Pseudomonas aeruginosa infections
    Harper, D. R.
    Enright, M. C.
    JOURNAL OF APPLIED MICROBIOLOGY, 2011, 111 (01) : 1 - 7
  • [43] Nosocomial infections caused by multiresistant Pseudomonas aeruginosa
    Arruda, EAG
    Marinho, IS
    Boulos, M
    Sinto, SI
    Caiaffa, HH
    Mendes, CM
    Oplustil, CP
    Sader, H
    Levy, CE
    Levin, AS
    INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY, 1999, 20 (09): : 620 - 623
  • [44] Pseudomonas aeruginosa Bacteriophages and Their Clinical Applications
    Alipour-Khezri, Elaheh
    Skurnik, Mikael
    Zarrini, Gholamreza
    VIRUSES-BASEL, 2024, 16 (07):
  • [45] INVITRO ACTIVITY OF MEROPENEM, A NEW CARBAPENEM, AGAINST MULTIRESISTANT PSEUDOMONAS-AERUGINOSA COMPARED WITH THAT OF OTHER ANTIPSEUDOMONAL ANTIMICROBIALS
    VOUTSINAS, D
    MAVROUDIS, T
    AVLAMIS, A
    GIAMARELLOU, H
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1989, 24 : 143 - 147
  • [46] Bacteriophages for the Disruption of Pseudomonas aeruginosa Biofilms
    Aslanov, Prof Batyrbek
    Konev, Sergey
    Pshenichnaya, Prof Natalia
    INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2025, 152
  • [47] NOSOCOMIAL COLONIZATION AND INFECTION BY MULTIRESISTANT PSEUDOMONAS-AERUGINOSA STRAINS IN AN INTENSIVE-CARE UNIT
    RITTER, E
    BAUERNFEIND, A
    SCHEMKENBIRK, EM
    URBANEK, C
    FINGER, H
    ZENTRALBLATT FUR HYGIENE UND UMWELTMEDIZIN, 1995, 197 (06): : 552 - 566
  • [48] VIRULENT BACTERIOPHAGE SPECIFIC FOR PSEUDOMONAS AERUGINOSA
    NERI, MG
    ZAMPIERI, A
    DETTORI, R
    GIORNALE DI MICROBIOLOGIA, 1966, 14 (2-3): : 107 - &
  • [49] New Strategy against Pseudomonas aeruginosa
    不详
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2016, 141 (09) : 597 - 597
  • [50] PATHOGENIC AND PHYLOGENETIC FEATURES OF 2 MULTIRESISTANT PSEUDOMONAS AERUGINOSA STRAINS ORIGINATED FROM REMEDIATED SITES
    Kaszab, Edit
    Szoboszlay, Sandor
    Dura, Gyula
    Rado, Julia
    Kovacs, Balazs
    Kriszt, Balazs
    INTERNATIONAL JOURNAL OF OCCUPATIONAL MEDICINE AND ENVIRONMENTAL HEALTH, 2016, 29 (03) : 503 - 516